REPH Overview
Upcoming Projects (REPH)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (REPH)
-
Don’t see a project related to the company you care about? Create your own!
Expired Projects (REPH)
-
Digging into the details of AcelRx's 1.1bn peak sales claim for ARX-04
Tickers: ACRX, REPH
Execute By: Jan 27, 2017
Upcoming & Overdue Catalysts (REPH)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (REPH)
-
Recro Pharma (REPH) to Submit New Drug Application to FDA in Summer 2017 for IV Meloxicam in Serious Acute Pain
Ticker: REPH
Occurred on: Jul 31, 2017 -
Recro (REPH) to Complete Enrollment for 700 Patient Safety Study of IV Meloxicam by Q1 or Early Q2
Ticker: REPH
Occurred on: Feb 27, 2017 -
Recro Pharma (REPH) Presents Phase 3 Results Evaluating IV Meloxicam in Serious Acute Pain
Ticker: REPH
Occurred on: Nov 28, 2016 -
Recro Pharma Reports Positive Top-Line Results from Pivotal Phase III Clinical Trial of IV Meloxicam
Ticker: REPH
Occurred on: Jul 26, 2016 -
Recro Pharma Initiates Pivotal Phase III Clinical Trial of IV Meloxicam for Acute Postoperative Pain
Ticker: REPH
Occurred on: Jan 27, 2016
Strategic Initiatives (REPH)
-
Don’t see a strategic initiative related to the company you care about? Create your own!